OnDemand
State of the Heart 2020
  • Detail & Program Access
  • Overview & Objectives
  • Credit Eligibility
  • Planning Committee
  • Agenda
  • Program Materials
  • Funding Support
Session 1 (Recorded Jul 22/2020)

Session 2 (Recorded Jul 29/2020)

Session 3 (Recorded Aug 5/2020)

Program Access and Details:

Program Length:
90 minutes

Resources:
DOWNLOADABLE SLIDES. View the Program Materials tab for more information.

Credits:
This program is not accredited. Physicians may earn self-learning credits through active steps. View more information under the Credit Eligibility tab.

Target Audience:
Family physicians, cardiovascular specialists, and allied health professionals

program advertising tile
Session 1 (Recorded Jul 22/2020)

Session 2 (Recorded Jul 29/2020)

Session 3 (Recorded Aug 5/2020)

Program Access and Details:

Program Length:
90 minutes

Resources:
DOWNLOADABLE SLIDES. View the Program Materials tab for more information.

Credits:
This program is not accredited. Physicians may earn self-learning credits through active steps. View more information under the Credit Eligibility tab.

Target Audience:
Family physicians, cardiovascular specialists, and allied health professionals

program advertising tile

CCRN sm

The State of the Heart program was developed by the Canadian Collaborative Research Network and has been specifically designed for family physicians, cardiovascular specialists and allied health professionals who have an interest in cardiovascular disease.

This program covers the latest topics in cardiovascular and metabolic disease, guidelines, late-breaking clinical trial results, and addresses patient care issues encountered in daily practice. For this program, CCRN hosts an outstanding faculty of Canadian and international leaders that provide excellent teaching and offers opportunities for group discussion surrounding real-world implications of the current evidence.

This program is NOT accredited.

Mainpro+ participants may earn certified credits by completing a Linking Learning Exercise.

Specialist participants may claim Section 2 credits (up to 2 credits per hour) following completion of a personal learning project (PLP) under Section 2: Self-Learning Activities within the MAINPORT ePortfolio. 

Milan Gupta
MD, FRCPC, FCCS, CPC(HC)
Brampton, ON
Rob Hegele
MD, FRCPC, FACP, FAHA, FCAHS, FCCS
London, Ontario
Alan Bell
MD, CCFP
Toronto, ON
Ajay Kapur
MD, FRCPC
Toronto, ON
Program Chapter
Presenter
Session 1 - Beyond statins: PCKS9 inhibitors following acute coronary syndromes – ODYSSEY Outcomes and EVOPACS
Rob Hegele
Session 1 - Beyond statins: Icosapent ethyl and the REDUCE-IT study
Milan Gupta
Session 1 - Does the PARAGON HF study provide a new option for treatment in HFpEF?
Shelley Zieroth
Session 1 - Is there an interaction between ACEi/ARB and COVID-19?
Nadia Khan
Session 2 - Antithrombotic combinations for AF with concomitant ACS/ PCI– clearing the confusion
Alan Bell
Session 2 - Cardiorenal protection in diabetes: Should SGLT2 inhibitors and GLP1 agonists be first-line therapy?
Hertzel Gerstein
Session 2 - Is dapagliflozin the new darling in heart failure management?
Nadia Giannetti
Session 2 - LDL control with twice-yearly injections – will ORION deliver?
Rob Hegele
Session 3 - Is colchicine a cardiovascular drug? Insights from the COLCOT study
Jean-Claude Tardif
Session 3 - Is revascularization warranted for stable ASCVD? The ISCHEMIA study
G.B. John Mancini
Session 3 - Peripheral arterial disease – underdiagnosed and undertreated
Milan Gupta
Session 3 - Cardiovascular safety of cannabis
Paul Oh

Program slides:

This program was developed by the Canadian Collaborative Research Network, a not-for-profit physician organization.  A PDF copy of the slides from this program are available for CCRN members from the CCRN website. Click the link below to be directed to the Resource Library.

Access CCRN Member Resource Library.

CCRN sm

This program was developed by the Canadian Collaborative Research Network and made possible through an educational grant from BMS/Pfizer Alliance, HLS Therapeutics, Boehringer Ingelheim, Novartis, Sanofi, Amgen

The OnDemand presentations were made possible with additional support from:

 

     

 

 

© 2020-2021 MDLearn, All Rights are Reserved